إعلان
إعلان
MRNA
Moderna, Inc. Common Stock
35.90
USDبرعاية
+0.24
+0.68%
٠٧ يناير, ١٣:٢٢ UTC -5
مفتوح
تقارير أرباح MRNA
النسبة الإيجابية المفاجئة
MRNA تفوق 19 من 28 آخر التقديرات.
68%
التقرير التالي
بيانات التقرير القادم
١٢ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$659.58M
/-$2.77
التغير الضمني من Q3 25 (Revenue/ EPS)
-35.08%
/+443.14%
التغير الضمني من Q4 24 (Revenue/ EPS)
-31.72%
/-4.81%
Moderna, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, MRNA reported earnings of -0.51 USD per share (EPS) for Q3 25, beating the estimate of -2.14 USD, resulting in a 76.27% surprise. Revenue reached 1.02 مليار, compared to an expected 904.27 مليون, with a 12.36% difference. The market reacted with a +3.27% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 18 المحللين forecast an EPS of -2.77 USD, with revenue projected to reach 659.58 مليون USD, implying an زيادة of 443.14% EPS, and نقصان of -35.08% in Revenue from the last quarter.
الأسئلة الشائعة
What were Moderna, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Moderna, Inc. Common Stock reported EPS of -$0.51, beating estimates by 76.27%, and revenue of $1.02B, 12.36% above expectations.
How did the market react to Moderna, Inc. Common Stock's Q3 2025 earnings?
The stock price moved up 3.27%, changed from $23.56 before the earnings release to $24.33 the day after.
When is Moderna, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٢ فبراير ٢٠٢٦.
What are the forecasts for Moderna, Inc. Common Stock's next earnings report?
Based on 18
المحللين, Moderna, Inc. Common Stock is expected to report EPS of -$2.77 and revenue of $659.58M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان